Figure 5.

Tumor-infiltrating IL-17A⁺ cells indicate enhanced anti-tumor immunity. (a) Difference in effector cytokines and proliferation marker expressed by CD8⁺ T cells in IL-17A⁺ cells low tumors and IL-17A⁺ cells high tumors. (b) Proportion of CD8⁺ T cells expressing effector cytokines and proliferation marker in CD45⁺ cells. (c) Difference in immunosuppressive molecules expressed by CD8⁺ T cells. (d) Proportion of CD8⁺ T cells expressing immunosuppressive molecules in CD45⁺ cells. (e and f) Effector cytokines and immunosuppressive molecules expressed by CD45⁺ cells in IL-17A⁺ cells low tumors and IL-17A⁺ cells high tumors.